The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungman, Per, Mikulska, Malgorzata, de la Camara, Rafael, Basak, Grzegorz W., Chabannon, Christian, Corbacioglu, Selim, Duarte, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Murray, John, Peffault de Latour, Régis, Snowden, John A., Yakoub-Agha, Ibrahim, Verhoeven, Bregje, Kröger, Nicolaus, Styczynski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220575/
https://www.ncbi.nlm.nih.gov/pubmed/32404975
http://dx.doi.org/10.1038/s41409-020-0919-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220575/
https://www.ncbi.nlm.nih.gov/pubmed/32404975
http://dx.doi.org/10.1038/s41409-020-0919-0

Ejemplares similares